Početna › Mikrocelularni karcinom pluća › Oregon
Kliničke studije za Mikrocelularni karcinom pluća u državi Oregon
9 studija za Mikrocelularni karcinom pluća traži sudionike na lokacijama u državi Oregon.
Gradovi u državi Oregon
Službeni tekst studije (engleski)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Oregon Health & Science University (OHSU), Portland
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04585750A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Willamette Valley Cancer Institute and Research Center /ID# 280617, Eugene
- Oregon Health and Science University /ID# 280071, Portland
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07365241A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- Providence Portland Medical Center ( Site 1101), Portland
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06780137A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Oncology Associates of Oregon, Eugene
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT06095505A Study of MGC026 in Participants With Advanced Solid Tumors
- Providence Cancer Institute, Portland
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT06242470A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Providence Portland Medical Center, Portland
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT06203210A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Providence Portland Medical Center, Portland
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 15. srp 2026. · NCT05652686Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- Providence Newberg Medical Center, Newberg
- Providence Willamette Falls Medical Center, Oregon City
- Providence Portland Medical Center, Portland
- i još 1
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ožu 2026. · NCT06769126A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- Oregon Health & Science University, Portland
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2025. · NCT06805825Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.